The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
Share This Story, Choose Your Platform!
About the Author: David Hilbern
